The AAIH hosted a live virtual presentation called Regulatory Update for AI-Enabled Hardware on January 11, 2022. This panel examined the rapidly changing landscape, and explored key considerations and potential disruptions on the pathway to regulatory approval and adoption for AI-enabled medical devices.

In today's rapidly evolving healthcare landscape, the absence of a unified patient record system remains a significant challenge. Join us for a thought-provoking panel discussion featuring the authors of the white paper, "Why Is There Currently No Unified Patient Record?" as they delve deep into the complexities, hurdles, and potential solutions surrounding this critical issue. Our expert panelists will share their insights, research findings, and recommendations for a future where seamless, comprehensive patient data sharing becomes a reality. Whether you're a healthcare professional, policymaker, or simply curious about the future of healthcare data, this discussion promises to shed light on one of the most pressing issues in the industry.

The advent of ChatGPT and other high-performing Large Language Models (LLMs) presents important opportunities for companies and the FDA to use generative AI to streamline the design and submission of high-quality NDA/BLA submissions.

This video examines how AI and machine learning represent advanced statistical techniques that derive insights from data. It highlights the iterative processes within machine learning, where systems continuously improve over time, and discusses how companies can harness these technologies to address the gap between diseases with limited treatment options and the slow drug approval process. The role of pharmaceutical firms in collaborating with AI startups and the importance of data aggregation, as illustrated by innovators like Tempus and Flatiron, is emphasized. Additionally, the video touches on the ethical challenges of healthcare innovation and the involvement of organizations like Count Me In in patient data contributions.